These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 8926682

  • 1. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
    Baersch G, Baumann M, Meltzer J, Möllers T, Ritter J, Jürgens H, Vormoor J.
    Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682
    [Abstract] [Full Text] [Related]

  • 2. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J, Orfao A, Vidriales B, Macedo A, Martínez A, González M, López-Berges MC, Valverde B, San Miguel JF.
    Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
    [Abstract] [Full Text] [Related]

  • 3. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y, Yoshida S, Saito Y, Doi T, Nagatoshi Y, Fukata M, Saito N, Yang SM, Iwamoto C, Okamura J, Liu KY, Huang XJ, Lu DP, Shultz LD, Harada M, Ishikawa F.
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [Abstract] [Full Text] [Related]

  • 4. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
    Hotfilder M, Röttgers S, Rosemann A, Schrauder A, Schrappe M, Pieters R, Jürgens H, Harbott J, Vormoor J.
    Cancer Res; 2005 Feb 15; 65(4):1442-9. PubMed ID: 15735032
    [Abstract] [Full Text] [Related]

  • 5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr 15; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 6. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J, Babusíková O, Kaiserová E, Jamárik M.
    Neoplasma; 1998 Apr 15; 45(4):231-6. PubMed ID: 9890666
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G, Stimpfl M, Kurz M, Printz D, Buchinger P, Fischmeister G, Hoecker P, Gadner H.
    Bone Marrow Transplant; 1996 Feb 15; 17(2):169-78. PubMed ID: 8640162
    [Abstract] [Full Text] [Related]

  • 12. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun 15; 26(6):327-31. PubMed ID: 16185473
    [Abstract] [Full Text] [Related]

  • 13. Lymphoblastic lymphoma.
    Cortelazzo S, Ponzoni M, Ferreri AJ, Hoelzer D.
    Crit Rev Oncol Hematol; 2011 Sep 15; 79(3):330-43. PubMed ID: 21273093
    [Abstract] [Full Text] [Related]

  • 14. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
    Kimlinger T, Witzig TE.
    Bone Marrow Transplant; 1997 Mar 15; 19(6):553-6. PubMed ID: 9085734
    [Abstract] [Full Text] [Related]

  • 15. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA, Gore SD, Stone KD, Civin CI.
    Leukemia; 1992 Apr 15; 6(4):233-9. PubMed ID: 1375301
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-level expression of a novel epitope of CD59 identifies a subset of CD34+ bone marrow cells highly enriched for pluripotent stem cells.
    Hill B, Rozler E, Travis M, Chen S, Zannetino A, Simmons P, Galy A, Chen B, Hoffman R.
    Exp Hematol; 1996 Jul 15; 24(8):936-43. PubMed ID: 8690053
    [Abstract] [Full Text] [Related]

  • 20. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
    Vercauteren S, Zapf R, Sutherland H.
    Cytotherapy; 2007 Jul 15; 9(2):194-204. PubMed ID: 17453971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.